Remote Monitored Systems PLC (LON:RMS), the company formerly known as Strat Aero, has been successfully accepted into the EU's KEEP+ funding innovation programme. The company’s specialist surveying and inspection business, Geocurve, will receive modest financial support from KEEP+ as it works with the University of Essex on “groundbreaking knowledge exchange, collaboration, contract research and innovation in the Virtual and Augmented Reality spaces (VR/AR)”.
An unnamed US biopharmaceutical company is to run the rule over ReNeuron Group Plc’s (LON:RENE) exosome drug delivery platform. Under the terms of the collaboration agreement, the biopharma will explore the use of exosomes as a potential delivery vehicle for synthetic oligonucleotides used in gene therapy.
Circassia Pharmaceuticals PLC (LON:CIR) said its cost containment efforts were showing results as it gave an upbeat assessment of the company’s growth prospects and provided revenue guidance for the 12 months just gone. Ahead of a meeting to approve its move to AIM, the speciality pharma, which is focused on respiratory disease, told shareholders it had a healthy cash cushion of £41mln.
Amryt Pharma PLC (LON:AMYT) is to enrol another 48 patients into the phase III trial of its AP101 skin disorder treatment. The cream is being developed to treat epidermolysis bullosa, a rare, inherited condition which occurs predominantly in children and makes skin fragile to even the faintest touch.
Franchise Brands plc (LON:FRAN) has announced a continuation of its share buy-back programme, with up to £200,000 of shares to be purchased before 30 June. The cash generative group said the programme is an offset to the dilutive impact of employee share option awards.
Keywords Studios PLC (LON:KWS) said that, further to its announcement on 21 December 2018, it has completed the acquisition of Sunny Side Up Creative Inc from its founder, Thomas Giroux, after all of the conditions were fulfilled.
BB Healthcare Trust PLC (LON:BBH) said it is satisfied that all inside information which the directors and the company may have to the current date has previously been notified to a regulatory information service, and therefore it is not prohibited from repurchasing its own securities, or issuing new securities, during the closed period which ends on the date of the announcement of the Annual Report for the year ended 30 November 2018.
Aminex PLC (LON:AEX) announced that at an extraordinary general meeting on Friday its shareholders passed a resolution approving the previously announced farmout of a 50% interest in the Ruvuma PSA to The Zubair Corporation LLC. Aminex PLC made a short presentation to shareholders at the EGM, a copy of which will be available on the company's website.
In a separate statement, Solo Oil PLC (LON:SOLO), which holds a 25% interest in the Ruvuma PSA, said its board is supportive of the Aminex farmout transaction and is pleased to have a further high quality partner join the project.